Skip to main content
Premium Trial:

Request an Annual Quote

Germany to Increase Viral Sequencing

Germany plans to boost its SARS-CoV-2 sequencing efforts, according to Reuters.

It adds that other countries like the UK and Denmark have robust coronavirus sequencing operations. The UK, for instance, began sequencing SARS-CoV-2 samples early in the pandemic through its COVID-19 Genomics UK consortium, and, last month, spotted a new variant that appears to be more easily transmitted.

A new draft order from the German Health Ministry would now require that 5 percent of patient samples that test positive for SARS-CoV-2 be sent for sequencing, Reuters reports, noting that the UK sequences between 5 percent and 10 percent of its positive samples. It adds that Germany would further provide laboratories €200 (US $243) for each sample sequenced.

"The 5 percent strike rate is quite doable," Evangelos Kotsopoulos, a board member of ALM, association of German diagnostic labs, tells Reuters. "The capacity is there, the equipment is there, the people are there."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.